{"disease":{"id":"leukaemia","name":"leukaemia"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06065852","title":"National Registry of Rare Kidney Diseases","phase":"","overall_status":"RECRUITING","enrollment_count":35000,"lead_sponsor_name":"UK Kidney Association","has_results":false},{"nct_id":"NCT05473325","title":"Benchtop NMR Spectroscopy for Assessment of Clinical Human Pathologies (BRANCH-P STUDY)","phase":"","overall_status":"UNKNOWN","enrollment_count":2000,"lead_sponsor_name":"Willows Health","has_results":false},{"nct_id":"NCT05286528","title":"Study to Evaluate Chronic Myeloid Leukemia Treatment Landscape and Real-life Treatment Outcomes in Hungary: Analysis of National Health Insurance Fund Database","phase":"","overall_status":"COMPLETED","enrollment_count":1484,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT06790680","title":"GITMO AML/MDS-Relapse Registry Study","phase":"","overall_status":"COMPLETED","enrollment_count":859,"lead_sponsor_name":"Gruppo Italiano Trapianto di Midollo Osseo","has_results":false},{"nct_id":"NCT07476729","title":"International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020)","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":750,"lead_sponsor_name":"Charite University, Berlin, Germany","has_results":false},{"nct_id":"NCT05893836","title":"Real-World Disease Management and Outcomes in Chronic Myeloid Leukaemia","phase":"","overall_status":"COMPLETED","enrollment_count":555,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false},{"nct_id":"NCT04728893","title":"Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":490,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":false},{"nct_id":"NCT01039376","title":"Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":480,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT00748189","title":"Ofatumumab + Chlorambucil vs Chlorambucil Monotherapy in Previously Untreated Patients With Chronic Lymphocytic Leukemia","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":447,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT07509151","title":"Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":420,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT06564038","title":"A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":408,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT00824265","title":"Ofatumumab Added to Fludarabine-Cyclophosphamide vs Fludarabine-Cyclophosphamide Combination in Relapsed Subjects With Chronic Lymphocytic Leukemia","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":365,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT04678869","title":"CiproPAL (Ciprofloxacin Prophylaxis in Acute Leukaemia)","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":313,"lead_sponsor_name":"University College, London","has_results":false},{"nct_id":"NCT01343173","title":"Multicenter Trial Estimating the Persistence of Molecular Remission in Chronic Myeloid Leukaemia in Long Term After Stopping Imatinib","phase":"NA","overall_status":"COMPLETED","enrollment_count":220,"lead_sponsor_name":"University Hospital, Bordeaux","has_results":false},{"nct_id":"NCT07167381","title":"xDRIVE for Florida-based Cancer Patients","phase":"NA","overall_status":"RECRUITING","enrollment_count":210,"lead_sponsor_name":"First Ascent Biomedical Inc.","has_results":false},{"nct_id":"NCT07117136","title":"Blinatumomab Consolidation in Real World","phase":"","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Medical College of Wisconsin","has_results":false},{"nct_id":"NCT07305337","title":"Randomised Controlled Trial of Artificial Intelligence-assisted Health Education","phase":"NA","overall_status":"RECRUITING","enrollment_count":196,"lead_sponsor_name":"Zhongnan Hospital","has_results":false},{"nct_id":"NCT06345365","title":"MA+AZA Regimen for the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML)","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":154,"lead_sponsor_name":"Zhongnan Hospital","has_results":false},{"nct_id":"NCT01890746","title":"A Safety and Efficacy Study of Eltrombopag in Subjects With AML","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":148,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT05645172","title":"Retention Rate of Acalabrutinib in a Non-interventional Setting","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":137,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT01699217","title":"Front-line Nilotinib Treatment of BCR-ABL+ Chronic Myeloid Leukaemia in Chronic Phase","phase":"","overall_status":"COMPLETED","enrollment_count":129,"lead_sponsor_name":"Gruppo Italiano Malattie EMatologiche dell'Adulto","has_results":false},{"nct_id":"NCT01313689","title":"Ofatumumab vs Physician's Choice in Subjects With Bulky Fludarabine-Refractory Chronic Lymphocytic Leukemia","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":122,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT04603872","title":"CAR-T Cells Combined With Dasatinib for Patients With Relapsed and/or Refractory B-cell Hematological Malignancies","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"Zhejiang University","has_results":false},{"nct_id":"NCT03873311","title":"Azacytidine + HAG Regimen vs. Azacytidine for Elderly Patients With Newly Diagnosed Myeloid Malignancy","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":114,"lead_sponsor_name":"Shenzhen Second People's Hospital","has_results":false},{"nct_id":"NCT03582098","title":"Clinical Outcomes and Routine Management of Adults With Chronic Lymphocytic Leukaemia Treated With Idelalisib and Rituximab in the United Kingdom (UK) and Ireland","phase":"","overall_status":"COMPLETED","enrollment_count":112,"lead_sponsor_name":"Gilead Sciences","has_results":false},{"nct_id":"NCT04175587","title":"Randomized,International Multi-center Clinical Trial of RIF Plus RA for Non-high-risk APL","phase":"PHASE3","overall_status":"UNKNOWN","enrollment_count":109,"lead_sponsor_name":"Peking University People's Hospital","has_results":false},{"nct_id":"NCT05682924","title":"Condition Vasoregulation Function Endothelium in Patients With CML Getting TKI II Generation Bosutinib","phase":"","overall_status":"RECRUITING","enrollment_count":105,"lead_sponsor_name":"Samara State Medical University","has_results":false},{"nct_id":"NCT07238907","title":"A Multi-center Retrospective Study of INO Treating B-ALL","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":102,"lead_sponsor_name":"Ruijin Hospital","has_results":false},{"nct_id":"NCT05086315","title":"First-in-human Study of SAR443579 Infusion in Male and Female Children and Adult Participants With Relapsed or Refractory Acute Myeloid Leukemia (R/R AML), B-cell Acute Lymphoblastic Leukemia (B-ALL), High Risk-myelodysplasia (HR-MDS), or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)","phase":"PHASE1, PHASE2","overall_status":"TERMINATED","enrollment_count":101,"lead_sponsor_name":"Sanofi","has_results":false},{"nct_id":"NCT06793410","title":"Vaccination Against Human Papillomavirus (HPV) After Allogeneic Stem Cell Transplantation","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Vastra Gotaland Region","has_results":false},{"nct_id":"NCT06783478","title":"NK Cell Infusion for Remission Consolidation in AML: A Phase II Trial","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":98,"lead_sponsor_name":"Hospital de Clinicas de Porto Alegre","has_results":false},{"nct_id":"NCT01659255","title":"Study to Evaluate the Safety and Tolerability of Tirabrutinib (ONO/GS-4059) Given as Monotherapy in Participants With Relapsed/Refractory NHL and CLL","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":90,"lead_sponsor_name":"Gilead Sciences","has_results":true},{"nct_id":"NCT05756322","title":"The Safety and Tolerability of LBS-007 in Patients With Relapsed or Resistant Acute Leukaemias","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":90,"lead_sponsor_name":"Lin BioScience, Inc","has_results":false},{"nct_id":"NCT07264010","title":"Sorafenib Combined With Venetoclax as Pre-emptive Therapy Strategy for MRD+ AML: a Prospective, Single-arm, Multicenter Clinical Study","phase":"PHASE2, PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":87,"lead_sponsor_name":"Nanfang Hospital, Southern Medical University","has_results":false},{"nct_id":"NCT02546375","title":"A Study To Describe The Real World Use Of Bosutinib In The UK And Netherlands","phase":"","overall_status":"COMPLETED","enrollment_count":87,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT07155226","title":"Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":84,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT07410676","title":"EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":83,"lead_sponsor_name":"Essen Biotech","has_results":false},{"nct_id":"NCT07244367","title":"Maintenance Venetoclax in AML Fit Patients","phase":"NA","overall_status":"RECRUITING","enrollment_count":80,"lead_sponsor_name":"Sohag University","has_results":false},{"nct_id":"NCT07200882","title":"What is the Impact of TKI on Thyroid Function in CML Patients?","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":76,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT06621212","title":"Mitoxantrone Hydrochloride Liposome, Standard-dose of Cytarabine and Venetoclax in the Treatment of R/R AML","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":72,"lead_sponsor_name":"First Affiliated Hospital of Zhejiang University","has_results":false},{"nct_id":"NCT02333058","title":"Treosulfan-based Conditioning in Paediatric Patients With Haematological Malignancies","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":70,"lead_sponsor_name":"medac GmbH","has_results":false},{"nct_id":"NCT07379528","title":"Mesenchymal Stem Cells in NPM1 Mutated Low Risk Acute Myeloid Leukemia: a Study of the Tumor Microenvironment and Its Contribution to the Outcome","phase":"","overall_status":"COMPLETED","enrollment_count":70,"lead_sponsor_name":"Fondazione IRCCS Policlinico San Matteo di Pavia","has_results":false},{"nct_id":"NCT05665374","title":"Calquence CLL 1L Japan PMS _ Japan Post-Marketing Surveillance (PMS) Study","phase":"","overall_status":"COMPLETED","enrollment_count":67,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT06947044","title":"Biomarkers in Patients With Anemia-Induced Thrombocytopenic Bleeding","phase":"NA","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"Donald Arnold","has_results":false},{"nct_id":"NCT02001818","title":"Pegylated Interferon Alfa-2b and Nilotinib for Augmentation of Complete Molecular Response in Chronic Myeloid Leukaemia","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Australasian Leukaemia and Lymphoma Group","has_results":false},{"nct_id":"NCT06651970","title":"Acalabrutinib Monotherapy vs Investigator's Choice of Treatment in Patients With CL Leukaemia and Heart Failure","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT05136378","title":"Selenious Yeast in CLL Patients w/o Indication of Chemotherapy","phase":"NA","overall_status":"UNKNOWN","enrollment_count":60,"lead_sponsor_name":"Shanghai Zhongshan Hospital","has_results":false},{"nct_id":"NCT06762431","title":"Phase I/II Open-label Study Evaluating The Safety And Efficacy of Concomitant Administration of Anti-CD19 CAR T-cell Therapy and Lenalidomide in Refractory/Relapsed Chronic Lymphocytic Leukemia Patients.","phase":"PHASE1, PHASE2","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":60,"lead_sponsor_name":"Vitebsk Regional Clinical Cancer Centre","has_results":false},{"nct_id":"NCT07249476","title":"Study of NK Cells in the Monitoring of Patients With Acute Leukemia or Myelodysplasia","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":55,"lead_sponsor_name":"Nantes University Hospital","has_results":false},{"nct_id":"NCT04326764","title":"Panobinostat Maintenance After HSCT fo High-risk AML and MDS","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":52,"lead_sponsor_name":"Goethe University","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}